Русский
Rare combination of ANCA-associated glomerulonephritis with systemic lupus erythematosus
DOI: https://dx.doi.org/10.18565/therapy.2023.3.78-82
Voloshinova E.V., Grigoryeva E.V., Nikitina N.M.
V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia
Literature
1. Kamen D.L. Environmental influences on systemic lupus erythematosus expression, rheumatic disease clinics of North America. 2014; 40(3): 401–11. https://dx.doi.org/10.1016/j.rdc.2014.05.003. 2. Agmon-Levin N., Mosca M., Petri M., Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev. 2012; 11(8): 593–95. https://dx.doi.org/10.1016/J.AUTREV.2011.10.020. 3. Jennette J.C., Falk R.J., Bacon P.A. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65(1): 1–11. https://dx.doi.org/10.1002/art.37715. 4. Shimizu T., Morita T., Kumanogoh A. The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: A meta-analysis. Rheumatology (Oxford). 2020; 59(5): 959–67. https://dx.doi.org/10.1093/rheumatology/kez311. 5. Choi M.Y., Fritzler M.J. Autoantibodies in SLE: Prediction and the p value matrix. Lupus. 2019; 28(11): 1285–93. https://dx.doi.org/10.1177/0961203319868531. 6. Leuchten N., Hoyer A., Brinks R. et al. Performance of antinuclear antibodies for classifying systemic lupus erythematosus: A systematic literature review and meta-regression of diagnostic data. Arthritis Care Res (Hoboken). 2018; 70(3): 428–38. https://dx.doi.org/10.1002/ACR.23292. 7. Hellmich B., Flossman O., Gross W.L. et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007; 66(5): 605–17. https://dx.doi.org/10.1136/ard.2006.062711. 8. Miloslavsky E.M., Specks U., Merkel P.A. et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2013; 65(9): 2441–49. https://dx.doi.org/10.1002/art.38044. 9. Fauzi A.R., Kong N.C., Chua M.K. et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: Prevalence, disease activity correlations and organ system associations. Med J Malaysia. 2004; 59(3): 372–77. 10. Старовойтова М. Н., Десинова О. В., Гусева Н. Г. Перекрестные формы системной склеродермии. Научно-практическая ревматология. 2007; 45(1): 52–57. [Starovoitova M.N., Desinova O.V., Guseva N.G. Cross forms of systemic scleroderma. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2007; 45(1): 52–57 (In Russ.)]. EDN: HZSMZR. 11. Jarrot P.-A., Chiche L., Hervier B. et al. Systemic lupus erythematosus and antineutrophil cytoplasmic antibodyassociated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis». Medicine. 2016; 95(22): e3748. https://dx.doi.org/10.1097/MD.0000000000003748. 12. Itikyala S., Pattanaik D., Raza S. Systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Overlap syndrome: Case report and review of the literature. Case Rep Rheumatol. 2019; 2019: 5013904. https://dx.doi.org/10.1155/2019/5013904. 13. Makiishi T., Shirase T., Yamamoto S., Maeda S. AP-VAS 2012 case report: A case of lupus nephritis with predominant synchronous cellular crescent formation and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity. CEN Case Rep. 2013; 2(2): 134–38. https://dx.doi.org/10.1007/s13730-012-0046-x. 14. Moiseev S., Cohen Tervaert J.W., Arimura Y. et al. 2020 International consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev. 2020; 19(9): 102618. https://dx.doi.org/10.1016/j.autrev.2020.102618. 15. Бекетова Т.В. Международные рекомендации по лечению АНЦА-ассоциированных системных васкулитов. Современная ревматология. 2019; 13(1): 19–25. [Beketova T.V. International guidelines for the treatment of ANCA-associated systemic vasculitis. Sovremennaya revmatologiya = Modern Rheumatology. 2019; 13(1): 19–25 (In Russ.)]. https://dx.doi.org/10.14412/1996-7012-2019-1-19-25. EDN: XEWKJG. 16. Российские клинические рекомендации. Ревматология. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2020; с. 131. [Russian clinical guidelines. Rheumatology. Ed. by Nasonov E.L. Moscow: GEOTAR-Media. 2020; p. 131 (In Russ.)]. ISBN: 978-5-9704-5398-8.
About the Autors
Elena V. Voloshinova, PhD in Medical Sciences, associate professor of the Department of hospital therapy, V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bolshaya Kazachya Str. E-mail: voloshinovaelena@mail.ru. ORCID: https://orcid.org/0000-0002-6883-0567
Elena V. Grigoryeva, PhD in Medical Sciences, associate professor of the Department of hospital therapy, V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bolshaya Kazachya Str. E-mail: lek133@yandex.ru. ORCID: https://orcid.org/0000-0001-6064-560X
Natalia M. Nikitina, MD, professor of the Department of hospital therapy, V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bolshaya Kazachya Str. E-mail: nikina02@yandex.ru. ORCID: https://orcid.org/0000-0002-0313-1191
Similar Articles
